Type 1 diabetes is another prototypic autoimmune disorder mediated by Th1 CD4 T cells and CTLs (34) where cell therapy approaches including MAPC cells (17, 18) and Tregs (47, 49, 50) show promise. This evidence concerns the gene CD4 and type 1 diabetes mellitus.